Alexis A Thompson

  • 9769 Citations
1993 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Alexis Thompson is currently the Hematology Section Head at Ann and Robert H. Lurie Children’s Hospital of Chicago in Chicago, Illinois. She holds the A. Watson and Sarah Armour Endowed Chair for Blood Diseases and Cancer at Lurie Children’s. She is also a Professor of Pediatrics at the Northwestern University Feinberg School of Medicine. Dr. Thompson is also the Associate Director for Equity and Minority Health at the Robert H. Lurie Cancer Center and Northwestern University Feinberg School of Medicine. She has served on regional and national on advisory committees for governmental agencies as well as non-profit organizations focused on improving healthcare access, increasing workforce diversity and reducing health disparities. Currently she is President of the American Society of Hematology.

In her current position, she is an investigator on multi-center trials and as well as her own institutional clinical studies in thalassemia, sickle cell disease and ITP. Her most significant scientific contributions are clinical and translation studies to better understand and treat hemoglobinopathies. She has been a leader in multicenter collaborations, such as the NHLBI-funded Thalassemia Clinical Research Network and the Sickle Cell Disease Implementation Consortium.

Her clinical interests include hemoglobinopathies (thalassemia and sickle cell disease), bone marrow failure syndromes and stem cell transplantation in pediatric patients.

Certifications and Licenses

Pediatrics
Pediatric Hematology-Oncology

Training Experience

1986Residency, Children's Hospital, Los Angeles
1990Fellowship, Children's Hospital of Philadelphia

Education/Academic qualification

MPH, University of California-Los Angeles

… → 1987

MD, Tulane University

… → 1983

Fingerprint Dive into the research topics where Alexis A Thompson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Sickle Cell Anemia Medicine & Life Sciences
Thalassemia Medicine & Life Sciences
Young Adult Medicine & Life Sciences
Sickle Cell Trait Medicine & Life Sciences
Iron Medicine & Life Sciences
Hydroxyurea Medicine & Life Sciences
Iron Overload Medicine & Life Sciences
Hemophilia A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2012 2022

Research Output 1993 2019

A targeted agent for sickle cell disease - Changing the protein but not the gene

Thompson, A. A., Aug 8 2019, In : New England Journal of Medicine. 381, 6, p. 579-580 2 p.

Research output: Contribution to journalEditorial

Sickle Cell Anemia
Proteins

Combination Oral Chelation in Adult Patients with Transfusion-dependent Thalassemia and High Iron Burden

Hammond, J., Thompson, A. A., Fogel, M. A., Hammond, K., Kokroko, J. & Kwiatkowski, J. L., Jan 1 2019, In : Journal of pediatric hematology/oncology. 41, 1, p. E47-E50

Research output: Contribution to journalArticle

Thalassemia
Iron
Chelation Therapy
Agranulocytosis
Iron Overload

Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia

Badawy, S. M., Morrone, K., Thompson, A. A. & Palermo, T. M., Jun 28 2019, In : Cochrane Database of Systematic Reviews. 2019, 6, CD012900.

Research output: Contribution to journalReview article

Thalassemia
Medication Adherence
Disease Management
Technology
Iron Overload

Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes

for the Joint Outcome Study Group Investigators, Sep 1 2019, In : Haemophilia. 25, 5, p. 867-875 9 p.

Research output: Contribution to journalArticle

Factor VIII
Hemophilia A
Hemostasis
Joints
Outcome Assessment (Health Care)
1 Citation (Scopus)

Immunosuppressive therapy for pediatric aplastic anemia: A North American Pediatric Aplastic Anemia Consortium study

Rogers, Z. R., Nakano, T. A., Olson, T. S., Bertuch, A. A., Wang, W., Gillio, A., Coates, T. D., Chawla, A., Castillo, P., Kurre, P., Gamper, C., Bennett, C. M., Joshi, S., Geddis, A. E., Boklan, J., Nalepa, G., Rothman, J. A., Huang, J. N., Kupfer, G. M., Cada, M. & 9 others, Glader, B., Walkovich, K. J., Thompson, A. A., Hanna, R., Vlachos, A., Malsch, M., Weller, E. A., Williams, D. A. & Shimamura, A., Jan 1 2019, In : Haematologica. 104, 10, p. 1974-1983 10 p.

Research output: Contribution to journalArticle

Open Access
Aplastic Anemia
Immunosuppressive Agents
Pediatrics
Antilymphocyte Serum
Horses